Conmed (CNMD) Tops Q1 EPS by 5c; Withdraws Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- S&P Global explores potential separation of Capital IQ business
- Equities end higher as Anthropic's IPO filing buoys AI stocks
CONMED Corporation Announces First Quarter 2020 Financial Results
April 29, 2020 4:05 PM EDTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2020.
First Quarter 2020 Highlights
Sales of $214.0 million decreased 2.0% year over year as reported and 0.7% in constant currency. Acquisitions contributed approximately 290 basis points of growth. Domestic revenue increased 1.6% year over year. International revenue decreased 6.1% as reported and 3.4% in constant currency. Diluted net earnings per share (GAAP) were $0.20, compared to diluted net earnings per share of $0.04 in the first quarter of 2019. Adjusted diluted net... More


